Author: David J Linshaw1, Erin G Floyd2, Kari M Rosenkranz3, James E Stahl4
1 Department of General Surgery, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH, 03756, USA. Electronic address: email@example.com.
2 Geisel School of Medicine at Dartmouth College, Dartmouth-Hitchcock Medical Center, Zimmerman Lounge Box 47, 1 Medical Center Drive, Lebanon, NH, 03756, USA. Electronic address: firstname.lastname@example.org.
3 Department of General Surgery, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH, 03756, USA. Electronic address: email@example.com.
4 Department of Internal Medicine, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH, 03756, USA. Electronic address: firstname.lastname@example.org.
Conference/Journal: Surg Oncol
Date published: 2020 Sep 1
Other: Volume ID: 34 , Pages: 63-66 , Special Notes: doi: 10.1016/j.suronc.2020.03.007. , Word Count: 252
Breast cancer is the most commonly diagnosed cancer in women in the United States. While improvements in treatment have improved mortality, they can negatively impact quality of life (QOL). Mindfulness-based programs are low-cost interventions shown to improve QOL. The study aim was to evaluate a well-validated mind-body program - determining its feasibility, acceptability, and improvement in symptomatology in post-operative breast cancer patients in a rural setting.
We recruited patients during post-operative appointments following mastectomy or lumpectomy for breast cancer. Each participant completed 3 surveys before and after the intervention: (8 PROMIS-29, PROMIS -Global QOL, and MAAS (Mindfulness Attention Awareness Scale). The intervention was an 8-week course: "The Stress Management and Resiliency Training (SMART) - Relaxation Response and Resiliency Program (3RP)", which has been well-validated for the treatment of various clinical problems. Feasibility, acceptability, quantitative survey data, and demographics were analyzed.
SMART-3RP was highly acceptable with greater than >80% completion rate. 23% of the invited participants enrolled, although over 70% of patients approached (34/48) expressed interest. The principal recruitment deterrent was scheduling. Sleep and anxiety/depression were improved in participants although not significantly due to small sample size. We also demonstrated improving trends in other QOL measures.
This small pilot study proved feasibility, showed excellent acceptability, and demonstrated a benefit in post-operative breast cancer patients. Even with our small sample size, we found trends in improvement in certain QOL measures which emphasizes SMART-3RP's potential effectiveness. A large-scale randomized controlled trial is warranted.
Keywords: Breast cancer; Relaxation response; Rural.
PMID: 32891355 DOI: 10.1016/j.suronc.2020.03.007